← Companies
AVADEL PHARMACEUTICALS PLC
Data as of Oct 16, 2026
Lobbying
$420,000 in reported federal lobbying spend across 7 quarterly filings, most recently Jul 5, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Pharmacy$420K7 filings
Latest filings, Apr 2025 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Jul 5, 2026 | LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS PLC Pharmacy Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act. VA Appropriations Request. | $60,000 |
| Apr 17, 2026 | LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS PLC Pharmacy Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act. VA Appropriations Request. | $60,000 |
| Jan 12, 2026 | LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS PLC Pharmacy Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act. VA Appropriations Request. | $60,000 |
| Oct 20, 2025 | LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS PLC Pharmacy Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act. VA Appropriations Request. | $60,000 |
| Jul 15, 2025 | LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS PLC Pharmacy Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act. VA Appropriations Request. | $60,000 |
| Apr 18, 2025 | LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS PLC Pharmacy Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act. | $60,000 |